Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patient’s own T cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK. 


Education

Biotechnology

Instil Bio

Bronson Crouch

Carol Castaneda

Jennifer Montoya

Artur Burgiel

Craig Kessler

T. David Chonzi

Sharon McGonagle

Film Sarah Turnbull Fcipd Fitol (Goodfellow)

Sandeep Laumas (Steve)

Robert Bob Hawkins

Mark Dudley

Sandeep Laumas

The Leadership Team at Instil Bio drives the strategic vision and operational execution of the company. Comprising experts in cell therapy and finance, this team fosters innovation in TIL development, oversees clinical trial advancements, and ensures robust financial health to support the company’s mission of revolutionizing cancer treatment through personalized therapies.

Leadership Team

Research and Development

Board & Executive Committee

Finance Team

��

Leadership Team

About

Team members

Other teams at Instil Bio

Research and Development

Board & Executive Committee

Finance Team

��������

Leadership Team

About

Team members

Other teams at Instil Bio

Research and Development

Board & Executive Committee

Finance Team

��